Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Unbounded-Parent-Physician Communication in the Era of Portal Messaging.

Lieu TA, Freed GL.

JAMA Pediatr. 2019 Jul 29. doi: 10.1001/jamapediatrics.2019.2309. [Epub ahead of print] No abstract available.

PMID:
31355855
2.

Developing a Prognostic Information System for Personalized Care in Real Time.

Lieu TA, Herrinton LJ, Buzkov DE, Liu L, Lyons D, Neugebauer R, Needham T, Ng D, Prausnitz S, Stewart K, Van Den Eeden SK, Baer DM.

EGEMS (Wash DC). 2019 Mar 25;7(1):2. doi: 10.5334/egems.266.

3.

Strategies for Building Delivery Science in an Integrated Health Care System.

Lieu TA, Madvig PR.

J Gen Intern Med. 2019 Jun;34(6):1043-1047. doi: 10.1007/s11606-018-4797-8. Epub 2019 Jan 25.

PMID:
30684194
4.

The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations.

Panattoni L, Lieu TA, Jayasekera J, O'Neill S, Mandelblatt JS, Etzioni R, Phelps CE, Ramsey SD.

Breast Cancer Res Treat. 2019 Jan;173(2):417-427. doi: 10.1007/s10549-018-4988-3. Epub 2018 Oct 10.

PMID:
30306429
5.

Cost Effectiveness of Gene Expression Profile Testing in Community Practice.

Chandler Y, Schechter CB, Jayasekera J, Near A, O'Neill SC, Isaacs C, Phelps CE, Ray GT, Lieu TA, Ramsey S, Mandelblatt JS.

J Clin Oncol. 2018 Feb 20;36(6):554-562. doi: 10.1200/JCO.2017.74.5034. Epub 2018 Jan 8.

6.

Racial disparities in family-provider interactions for pediatric asthma care.

Trivedi M, Fung V, Kharbanda EO, Larkin EK, Butler MG, Horan K, Lieu TA, Wu AC.

J Asthma. 2018 Apr;55(4):424-429. doi: 10.1080/02770903.2017.1337790. Epub 2017 Jul 14.

7.

Evaluating Frameworks That Provide Value Measures for Health Care Interventions.

Mandelblatt JS, Ramsey SD, Lieu TA, Phelps CE.

Value Health. 2017 Feb;20(2):185-192. doi: 10.1016/j.jval.2016.11.013.

8.

Applied Research and Development in Health Care - Time for a Frameshift.

Lieu TA, Platt R.

N Engl J Med. 2017 Feb 23;376(8):710-713. doi: 10.1056/NEJMp1611611. No abstract available.

PMID:
28225671
9.

Oncologist and organizational factors associated with variation in breast cancer multigene testing.

Lieu TA, Ray GT, Prausnitz SR, Habel LA, Alexeeff S, Li Y, Ramsey SD, Phelps CE, Chawla N, C O'Neill S, Mandelblatt JS.

Breast Cancer Res Treat. 2017 May;163(1):167-176. doi: 10.1007/s10549-017-4158-z. Epub 2017 Feb 21.

10.

Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban.

Galbraith AA, Fung V, Li L, Butler MG, Nordin JD, Hsu J, Smith D, Vollmer WM, Lieu TA, Soumerai SB, Wu AC.

Health Serv Res. 2018 Feb;53(1):156-174. doi: 10.1111/1475-6773.12615. Epub 2016 Nov 20.

11.

Parental weighting of seizure risks vs. fever risks in vaccination tradeoff decisions.

Zikmund-Fisher BJ, Wittenberg E, Lieu TA.

Vaccine. 2016 Dec 7;34(50):6123-6125. doi: 10.1016/j.vaccine.2016.10.030. Epub 2016 Nov 3.

PMID:
27817959
12.

Breast cancer multigene testing trends and impact on chemotherapy use.

Ray GT, Mandelblatt J, Habel LA, Ramsey S, Kushi LH, Li Y, Lieu TA.

Am J Manag Care. 2016 May 1;22(5):e153-60.

13.

Mismatching Among Guidelines, Providers, and Parents on Controller Medication Use in Children with Asthma.

Wu AC, Li L, Fung V, Kharbanda EO, Larkin EK, Butler MG, Galbraith A, Miroshnik I, Davis RL, Horan K, Lieu TA.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):910-6. doi: 10.1016/j.jaip.2016.04.004. Epub 2016 May 17.

14.

Parents' Perspectives on How to Improve the Childhood Vaccination Process.

Lieu TA, Zikmund-Fisher BJ, Chou C, Ray GT, Wittenberg E.

Clin Pediatr (Phila). 2017 Mar;56(3):238-246. doi: 10.1177/0009922816649001. Epub 2016 Jul 20.

PMID:
27162178
15.

Building Data Infrastructure to Evaluate and Improve Quality: PCORnet.

Corley DA, Feigelson HS, Lieu TA, McGlynn EA.

J Oncol Pract. 2015 May;11(3):204-6. doi: 10.1200/JOP.2014.003194. No abstract available.

16.

A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program.

Baker MA, Lieu TA, Li L, Hua W, Qiang Y, Kawai AT, Fireman BH, Martin DB, Nguyen MD.

Am J Epidemiol. 2015 Apr 15;181(8):608-18. doi: 10.1093/aje/kwu322. Epub 2015 Mar 13.

PMID:
25769306
17.

Geographic clusters in underimmunization and vaccine refusal.

Lieu TA, Ray GT, Klein NP, Chung C, Kulldorff M.

Pediatrics. 2015 Feb;135(2):280-9. doi: 10.1542/peds.2014-2715. Epub 2015 Jan 19.

18.

Primary adherence to controller medications for asthma is poor.

Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Miroshnik I, Davis RL, Lieu TA, Soumerai SB.

Ann Am Thorac Soc. 2015 Feb;12(2):161-6. doi: 10.1513/AnnalsATS.201410-459OC.

19.

Responding to vaccine safety signals during pandemic influenza: a modeling study.

Maro JC, Fryback DG, Lieu TA, Lee GM, Martin DB.

PLoS One. 2014 Dec 23;9(12):e115553. doi: 10.1371/journal.pone.0115553. eCollection 2014.

20.

Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.

Wu AC, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, Butler MG, Miroshnik I, Rusinak D, Davis RL, Hartert T, Weiss ST, Lieu TA.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):607-13. doi: 10.1016/j.jaip.2014.05.009. Epub 2014 Jul 25.

21.

Parents' choices and rationales for alternative vaccination schedules: a qualitative study.

Saada A, Lieu TA, Morain SR, Zikmund-Fisher BJ, Wittenberg E.

Clin Pediatr (Phila). 2015 Mar;54(3):236-43. doi: 10.1177/0009922814548838. Epub 2014 Sep 7.

PMID:
25200366
22.

Developing a data infrastructure for a learning health system: the PORTAL network.

McGlynn EA, Lieu TA, Durham ML, Bauck A, Laws R, Go AS, Chen J, Feigelson HS, Corley DA, Young DR, Nelson AF, Davidson AJ, Morales LS, Kahn MG.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):596-601. doi: 10.1136/amiajnl-2014-002746. Epub 2014 May 12.

23.

Intussusception risk after rotavirus vaccination in U.S. infants.

Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M.

N Engl J Med. 2014 Feb 6;370(6):503-12. doi: 10.1056/NEJMoa1303164. Epub 2014 Jan 14.

24.

Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.

Baker MA, Nguyen M, Cole DV, Lee GM, Lieu TA.

Vaccine. 2013 Dec 30;31 Suppl 10:K98-112. doi: 10.1016/j.vaccine.2013.04.088.

PMID:
24331080
25.

Some families who purchased health coverage through the Massachusetts Connector wound up with high financial burdens.

Galbraith AA, Sinaiko AD, Soumerai SB, Ross-Degnan D, Dutta-Linn MM, Lieu TA.

Health Aff (Millwood). 2013 May;32(5):974-83. doi: 10.1377/hlthaff.2012.0864. Epub 2013 Apr 17.

26.

Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010.

Greene SK, Li L, Shay DK, Fry AM, Lee GM, Jacobsen SJ, Baxter R, Irving SA, Jackson ML, Naleway AL, Nordin JD, Narwaney KJ, Lieu TA.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):335-44. doi: 10.1002/pds.3363. Epub 2012 Nov 5.

PMID:
23129321
27.
28.

Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA.

Influenza Other Respir Viruses. 2012 Nov;6(6):e143-51. doi: 10.1111/j.1750-2659.2012.00390.x. Epub 2012 Jun 11.

29.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

30.

Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA.

Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11.

PMID:
22582207
31.

Parental and societal values for the risks and benefits of childhood combination vaccines.

Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA.

Vaccine. 2012 May 14;30(23):3445-52. doi: 10.1016/j.vaccine.2012.03.022. Epub 2012 Mar 23.

PMID:
22449423
32.

Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program.

Lieu TA, Nguyen MD, Ball R, Martin DB.

Vaccine. 2012 Apr 16;30(18):2824-30. doi: 10.1016/j.vaccine.2012.02.057. Epub 2012 Mar 3.

PMID:
22394993
33.

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.

Nguyen M, Ball R, Midthun K, Lieu TA.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:291-7. doi: 10.1002/pds.2323.

PMID:
22262619
34.

Delayed and forgone care for families with chronic conditions in high-deductible health plans.

Galbraith AA, Soumerai SB, Ross-Degnan D, Rosenthal MB, Gay C, Lieu TA.

J Gen Intern Med. 2012 Sep;27(9):1105-11. doi: 10.1007/s11606-011-1970-8. Epub 2012 Jan 18.

35.

The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.

O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R.

Pediatrics. 2012 Feb;129(2):248-55. doi: 10.1542/peds.2011-1111. Epub 2012 Jan 9.

PMID:
22232308
36.

Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitus.

Rhodes ET, Goran MI, Lieu TA, Lustig RH, Prosser LA, Songer TJ, Weigensberg MJ, Weinstock RS, Gonzalez T, Rawluk K, Zoghbi RM, Ludwig DS, Laffel LM.

J Pediatr. 2012 Jun;160(6):911-7. doi: 10.1016/j.jpeds.2011.11.026. Epub 2012 Jan 3.

37.

Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries.

Nakamura MM, Tasslimi A, Lieu TA, Levine O, Knoll MD, Russell LB, Sinha A.

Int Health. 2011 Dec;3(4):270-81. doi: 10.1016/j.inhe.2011.08.004.

PMID:
24038500
38.

Collaborations in population-based health research: the 17th annual HMO Research Network Conference, March 23-25, 2011, Boston, Massachusetts, USA.

Lieu TA, Hinrichsen VL, Moreira A, Platt R.

Clin Med Res. 2011 Nov;9(3-4):137-40. doi: 10.3121/cmr.2011.1025.

39.

Financing and systems barriers to seasonal influenza vaccine delivery in community settings.

Penfold RB, Rusinak D, Lieu TA, Shefer A, Messonnier M, Lee GM.

Vaccine. 2011 Dec 6;29(52):9632-9. doi: 10.1016/j.vaccine.2011.10.041. Epub 2011 Oct 25.

PMID:
22036886
40.

Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop.

Lieu TA, Au D, Krishnan JA, Moss M, Selker H, Harabin A, Taggart V, Connors A; Comparative Effectiveness Research in Lung Diseases Workshop Panel.

Am J Respir Crit Care Med. 2011 Oct 1;184(7):848-56. doi: 10.1164/rccm.201104-0634WS.

41.

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA; Vaccine Safety Datalink Project.

Am J Prev Med. 2011 Aug;41(2):121-8. doi: 10.1016/j.amepre.2011.04.004.

PMID:
21767718
42.

Reliability of a patient survey assessing cost-related changes in health care use among high deductible health plan enrollees.

Penfold RB, Kullgren JT, Miroshnik I, Galbraith AA, Hinrichsen VL, Lieu TA.

BMC Health Serv Res. 2011 May 27;11:133. doi: 10.1186/1472-6963-11-133.

43.

Near real-time vaccine safety surveillance with partially accrued data.

Greene SK, Kulldorff M, Yin R, Yih WK, Lieu TA, Weintraub ES, Lee GM.

Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):583-90. doi: 10.1002/pds.2133.

PMID:
21538670
44.

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.

Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, Baggs J, Weintraub ES, Belongia EA, Naleway A, Gee J, Platt R, Lieu TA.

Pediatrics. 2011 May;127 Suppl 1:S54-64. doi: 10.1542/peds.2010-1722I. Epub 2011 Apr 18.

PMID:
21502252
45.

Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitus.

Rhodes ET, Prosser LA, Lieu TA, Songer TJ, Ludwig DS, Laffel LM.

Pediatr Diabetes. 2011 Dec;12(8):724-32. doi: 10.1111/j.1399-5448.2011.00772.x. Epub 2011 Apr 13.

46.

Healthcare utilization and cost of pneumococcal disease in the United States.

Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA.

Vaccine. 2011 Apr 18;29(18):3398-412. doi: 10.1016/j.vaccine.2011.02.088. Epub 2011 Mar 11.

47.

Use of well-child visits in high-deductible health plans.

Galbraith AA, Ross-Degnan D, Soumerai SB, Abrams AM, Kleinman K, Rosenthal MB, Wharam JF, Adams AS, Miroshnik I, Lieu TA.

Am J Manag Care. 2010 Nov;16(11):833-40.

48.

Nearly half of families in high-deductible health plans whose members have chronic conditions face substantial financial burden.

Galbraith AA, Ross-Degnan D, Soumerai SB, Rosenthal MB, Gay C, Lieu TA.

Health Aff (Millwood). 2011 Feb;30(2):322-31. doi: 10.1377/hlthaff.2010.0584.

49.

Financial barriers to the adoption of combination vaccines by pediatricians.

Gidengil CA, Dutta-Linn MM, Messonnier ML, Rusinak D, Lieu TA.

Arch Pediatr Adolesc Med. 2010 Dec;164(12):1138-44. doi: 10.1001/archpediatrics.2010.222.

PMID:
21135343
50.

Health care use and decision making among lower-income families in high-deductible health plans.

Kullgren JT, Galbraith AA, Hinrichsen VL, Miroshnik I, Penfold RB, Rosenthal MB, Landon BE, Lieu TA.

Arch Intern Med. 2010 Nov 22;170(21):1918-25. doi: 10.1001/archinternmed.2010.428.

Supplemental Content

Support Center